Whalesbook
Coastal Corporation Reports Mixed Q3 FY26; Auditor Raises Significant Concerns
Coastal Corporation Limited announced its third-quarter financial results for the period ending December 31, 2025, revealing a dual picture of top-line growth marred by profitability concerns and critical auditor remarks. The company's Board of Directors approved the Un-Audited Standalone and Consolidated Financial Results on February 12, 2026.
Financial Performance: A Tale of Two Sides
On a standalone basis, Coastal Corporation saw its Total Revenue climb by a healthy 20.24% year-on-year to ₹178.43 Crores from ₹148.39 Crores in the same quarter last year. However, this revenue growth did not translate to the bottom line. Profit Before Tax (PBT) plunged 37.45% to ₹3.99 Crores, and consequently, Standalone Net Profit declined by 31.64% YoY to ₹3.16 Crores.
The consolidated numbers presented a different narrative for PBT, which surged 77.17% to ₹7.41 Crores from ₹4.18 Crores. Consolidated Revenue also saw a modest increase of 7.81% to ₹308.14 Crores. Despite the strong PBT growth, Consolidated Net Profit experienced a decline of 13.98% YoY, falling to ₹55.13 Crores from ₹6.41 Crores. It is important to note a discrepancy in the provided figures, as ₹55.13 Crores represents a substantial increase from ₹6.41 Crores, yet the report states a decline. Investors should seek clarification on this specific net profit figure.
The company attributed standalone revenue growth to its marine products and solar power segments. The commencement of grain-based Ethanol sales by its subsidiary, Coastal Biotech Private Limited, to Oil Marketing Companies (OMCs) is a new development that could bolster future revenues.
⚠️ Investor Risks & Governance Concerns
The most significant red flag emerges from the Limited Review Report. The auditors expressed that they are "unable to express an opinion" on the lack of provision for an impairment loss of ₹25.00 Crores on the company's investment in its wholly-owned foreign subsidiary, M/s. Seacrest Seafoods Inc. While the Board of Directors believes no impairment loss has occurred, the auditor's inability to form an opinion on such a material amount signals a potential overvaluation of assets or significant underlying issues within the subsidiary that are not being adequately addressed or disclosed.
Further adding to governance scrutiny, the auditors noted that the financial statements of another wholly-owned foreign subsidiary were not audited or reviewed by their own auditors. Instead, they were based solely on management-certified conversion statements. Although the management deemed these financials not material to the Group, this reliance on internal certification for foreign operations raises questions about transparency and the robustness of internal controls.
The company also confirmed no deviation in the use of funds raised through its Rights Issue of Partly Paid-Up Equity Shares in August 2022, totalling ₹42.40 Crores. These funds were utilized for investments in subsidiaries Coastal Biotech Private Limited and Continental Fisheries India Limited, issue expenses, and general corporate purposes.
Peer Comparison
Competitors in the marine products export sector, such as Apex Frozen Foods, often face volatile raw material costs and global demand fluctuations. If competitors are managing margins better, Coastal Corporation's standalone profitability dip warrants closer examination of operational efficiencies. In the burgeoning ethanol sector, driven by government mandates for blending, Coastal Biotech's entry adds a new revenue stream. However, the overall impact needs to be seen against established players.
The Forward View
Investors will be keenly watching how Coastal Corporation addresses the auditor's concerns regarding Seacrest Seafoods Inc. Clarity on the subsidiary's valuation and performance, along with robust governance practices for foreign operations, will be crucial. The success of the new ethanol business will also be a key monitorable in the coming quarters.